Buscar
Qiagen NV
QGENAñadir a la lista de seguimiento
40.100USD
+0.980+2.50%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
8.27BCap. mercado
21.46P/E TTM
Más Datos de Qiagen NV Compañía
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Información de Qiagen NV
Símbolo de cotizaciónQGEN
Nombre de la empresaQiagen NV
Fecha de salida a bolsaSep 01, 1996
Director ejecutivoBernard (Thierry)
Número de empleados5765
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 01
DirecciónHulsterweg 82
CiudadVENLO
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísNetherlands
Código postal5912 PL
Teléfono31773556600
Sitio Webhttps://www.qiagen.com/
Símbolo de cotizaciónQGEN
Fecha de salida a bolsaSep 01, 1996
Director ejecutivoBernard (Thierry)
Ejecutivos de Qiagen NV
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Thierry Bernard
Mr. Thierry Bernard
Chief Executive Officer, Managing Director, Member of the Executive Board
Chief Executive Officer, Managing Director, Member of the Executive Board
374.74K
+20.87%
Mr. Roland Sackers
Mr. Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Managing Director, Chief Financial Officer, Member of the Executive Board
349.19K
-4.22%
Dr. Metin Colpan, Ph.D.
Dr. Metin Colpan, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
167.23K
+2.41%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
49.12K
+8.67%
Prof. Dr. Ross L. Levine, M.D.
Prof. Dr. Ross L. Levine, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
15.46K
+23.57%
Prof. Dr. Elaine R. Mardis, Ph.D.
Prof. Dr. Elaine R. Mardis, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
3.77K
--
Mr. Stephen H. (Steve) Rusckowski
Mr. Stephen H. (Steve) Rusckowski
Independent Chairman of the Supervisory Board
Independent Chairman of the Supervisory Board
22.00
-4.55%
Dr. Toralf Haag, Ph.D.
Dr. Toralf Haag, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Eva Pisa, Ph.D.
Dr. Eva Pisa, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Bert van Meurs
Mr. Bert van Meurs
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Thierry Bernard
Mr. Thierry Bernard
Chief Executive Officer, Managing Director, Member of the Executive Board
Chief Executive Officer, Managing Director, Member of the Executive Board
374.74K
+20.87%
Mr. Roland Sackers
Mr. Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Managing Director, Chief Financial Officer, Member of the Executive Board
349.19K
-4.22%
Dr. Metin Colpan, Ph.D.
Dr. Metin Colpan, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
167.23K
+2.41%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
49.12K
+8.67%
Prof. Dr. Ross L. Levine, M.D.
Prof. Dr. Ross L. Levine, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
15.46K
+23.57%
Prof. Dr. Elaine R. Mardis, Ph.D.
Prof. Dr. Elaine R. Mardis, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
3.77K
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Qiagen NV?
Los cinco principales accionistas de Qiagen NV son: Mr. Thierry Bernard
¿Cuántas instituciones poseen acciones de Qiagen NV (QGEN)?
A fecha de 2026Q1, 1005 instituciones poseen acciones de Qiagen NV, con un valor de mercado combinado de aproximadamente 161.40M, lo que representa el 78.32% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -30070961.00.
¿Cuál es la mayor fuente de ganancias de Qiagen NV?
El 2026Q1, el segmento empresarial Consumables and Related Revenues generó la ganancia más alta para Qiagen NV, ascendiendo a 1.88B y representando el 89.78% de la ganancia total.